Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer
NCT00263588
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
242
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Breast
Interventions
DRUG:
lapatinib
Sponsor
Novartis Pharmaceuticals